Pharmacogenomics Clinical Decision Support Systems

[1] DYLAN BOB., 1964, TIMES THEY ARE A CHA

[2] Terminology and the construction of scientific disciplines: The case of pharmacogenomics [J]. SCIENCE TECHNOLOGY & HUMAN VALUES, 2003, 28 (04) : 513 - 537

[3] Kalow W, 2001, Pharmacogenomics J, V1, P234

[4] Kalow W., 1962, Pharmacogenetics: Heredity and the response to drugs

[5] Digital Transformation in Personalized Medicine with Artificial Intelligence and the Internet of Medical Things [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2022, 26 (02) : 77 - 81

[6] Genset-Abbott deal heralds pharmacogenomics era [J]. NATURE BIOTECHNOLOGY, 1997, 15 (09) : 829 - 830

[7] DRUG REACTIONS, ENZYMES, AND BIOCHEMICAL GENETICS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 165 (07): : 835 - 837

[8] Ozdemir V., 2005, Current Pharmacogenomics, V3, P53, DOI 10.2174/1570160053175027

[1] DYLAN BOB., 1964, TIMES THEY ARE A CHA

[2] Terminology and the construction of scientific disciplines: The case of pharmacogenomics [J]. SCIENCE TECHNOLOGY & HUMAN VALUES, 2003, 28 (04) : 513 - 537

[3] Kalow W, 2001, Pharmacogenomics J, V1, P234

[4] Kalow W., 1962, Pharmacogenetics: Heredity and the response to drugs

[5] Digital Transformation in Personalized Medicine with Artificial Intelligence and the Internet of Medical Things [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2022, 26 (02) : 77 - 81

[6] Genset-Abbott deal heralds pharmacogenomics era [J]. NATURE BIOTECHNOLOGY, 1997, 15 (09) : 829 - 830

[7] DRUG REACTIONS, ENZYMES, AND BIOCHEMICAL GENETICS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 165 (07): : 835 - 837

[8] Ozdemir V., 2005, Current Pharmacogenomics, V3, P53, DOI 10.2174/1570160053175027